The metabolic fate of nitroglycerin (trinitrin) in relation to its vascular effects.
D000273:Adipose Tissue / Q000032:analysis; D000284:Administration, Oral; D000818:Animals; D001794:Blood Pressure / Q000187:drug effects*; D001808:Blood Vessels / Q000187:drug effects; D004285:Dogs; D004912:Erythrocytes / Q000032:analysis; D007275:Injections, Intravenous; D007668:Kidney / Q000032:analysis; D008099:Liver / Q000032:analysis; D008168:Lung / Q000032:analysis; D009132:Muscles / Q000032:analysis; D009206:Myocardium / Q000032:analysis; D009566:Nitrates / Q000032:analysis; D005996:Nitroglycerin / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000494:pharmacology; D010634:Phenobarbital / Q000494:pharmacology; D011335:Proadifen / Q000494:pharmacology; D011817:Rabbits
D009566:Nitrates; D011335:Proadifen; D005996:Nitroglycerin; D010634:Phenobarbital